Lexicon Pharmaceuticals (LXRX) Payables (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Payables of $3.0 million for Q1 2026, down 71.97% year-over-year from $10.7 million in Q1 2025, and down 2.82% quarter-over-quarter from $3.1 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Payables (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Payables for 17 consecutive years, with $3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Payables fell 71.97% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (down 71.97% YoY), while the FY2025 annual figure was $3.1 million, down 79.17% from the prior year.
- Payables eased to $3.0 million in Q1 2026 per LXRX's latest filing, from $3.1 million in the prior quarter.
- Across five years, Payables topped out at $14.8 million in Q4 2024 and bottomed at $3.0 million in Q1 2026.
- Historically, Payables has averaged $9.4 million across 5 years, with a median of $10.3 million in 2023.
- Annual changes were most pronounced in 2022 — Payables jumped 89.22% — and 2025, when it plunged 79.17%.
- Lexicon Pharmaceuticals' Payables stood at $10.4 million in 2022, then jumped by 38.42% to $14.4 million in 2023, then rose by 2.86% to $14.8 million in 2024, then slumped by 79.17% to $3.1 million in 2025, then decreased by 2.82% to $3.0 million in 2026.
- Business Quant data shows LXRX's Payables at $3.0 million in Q1 2026, $3.1 million in Q4 2025, and $3.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | 2.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.34 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 3.08 Mn |
| Sep 30, 2025 | 3.80 Mn |
| Jun 30, 2025 | 5.90 Mn |
| Mar 31, 2025 | 10.69 Mn |
| Dec 31, 2024 | 14.80 Mn |
| Sep 30, 2024 | 14.20 Mn |
| Jun 30, 2024 | 12.22 Mn |
| Mar 31, 2024 | 8.07 Mn |
| Dec 31, 2023 | 14.39 Mn |
| Sep 30, 2023 | 12.04 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | 10.31 Mn |
| Dec 31, 2022 | 10.40 Mn |
| Sep 30, 2022 | 9.43 Mn |
| Jun 30, 2022 | 7.35 Mn |
| Mar 31, 2022 | 9.32 Mn |
| Dec 31, 2021 | 9.15 Mn |
| Sep 30, 2021 | 8.35 Mn |